Sala acquired and Swedish drilling
Sala was acquired in February 2021. Drilling and interpretation at Greater Falun developed the exploration programme; historical mine production is not current sales.
Alicanto’s FY2025 loss narrowed sharply and cash recovered, but those outcomes have different explanations. Exploration spending declined and a large non-cash share-payment reversal helped earnings; equity raising replenished the bank balance. The report keeps all three effects separate.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
Higher after equity funding.
Includes a non-cash net benefit.
FY2025 total, not plus A$3m again.
FY2025 operating outflow component.
Alicanto focused on Sweden’s Falun and Sala projects while disposing of Arakaka in Guyana. Historic mine production is context for exploration, not Alicanto’s current-period production or sales.
Exploration is expensed as incurred except for capitalised acquisition costs. Falun’s acquisition mixed cash and shares; neither the acquisition carrying value nor the Sala Inferred Resource is treated as a forecast financial return.
Sala was acquired in February 2021. Drilling and interpretation at Greater Falun developed the exploration programme; historical mine production is not current sales.
The Guyana sale completed in January 2022. Its potential milestone-linked consideration was not all immediate cash; Sala drilling supported a resource announced after June year-end.
The maiden Sala Inferred Resource was announced in July 2022. Falun’s historic mine permit acquisition completed in May 2023 with cash plus scrip consideration.
Exploration continued around Falun and Sala. The June board restructure accompanied an expanded strategy to consider complementary advanced projects.
Five equity issuances replenished funds while options and performance rights were cancelled or forfeited. The accounting write-backs were separate from cash proceeds.
Operating cash outflow fell as exploration payments declined. Financing exceeded the combined operating and investing cash requirement in FY2025, producing a larger closing balance. The going-concern uncertainty remained disclosed.
A$ million
AI-generated presentation · values from Cash flows and year-end liquidity; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Cash flows and year-end liquidity; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | (4.297) | (8.309) | (5.978) | (5.006) | (2.726) |
| Investing cash flow | (0.455) | 0.751 | 0.300 | (0.001) | 0.031 |
| Financing cash flow | 6.832 | 6.297 | 5.494 | 2.743 | 4.534 |
| Closing cash | 4.513 | 3.252 | 3.068 | 0.804 | 2.642 |
| Exploration payments within operating | (3.244) | (6.892) | (3.745) | (3.411) | (0.684) |
Years ended 30 June; A$ million. Exploration payments are included in operating cash, not additional to it.
FY2023 investing inflow included the release of security deposits; it is not exploration revenue.
FY2024 closing cash and FY2023 closing cash are taken from the statement series, not a mismatched FY2025-extraction opening comparator.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The FY2025 net share-based benefit arose because reversals exceeded new performance-right expense. The new rights still generated an expense; the result is not evidence that no incentives were issued or that the company received cash from cancellations.
A$ million
AI-generated presentation · values from Smaller losses reflect lower exploration and a non-cash reversal; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Loss after tax, total operations | (7.361) | (9.936) | (7.046) | (5.470) | (0.942) |
| Exploration expense, continuing operations | (2.574) | (6.287) | (3.808) | (3.319) | (0.713) |
| Share-based payment expense / net benefit | (1.024) | (0.362) | (0.225) | (0.359) | 1.782 |
| Employee benefit expense | (0.416) | (0.481) | (0.789) | (0.680) | (0.926) |
| Consultancy expense | (1.986) | (1.788) | (1.187) | (0.551) | (0.458) |
FY2021 uses the restated comparative separating Arakaka discontinued operations; total loss still includes those operations. FY2022 total loss includes A$0.399m discontinued loss.
Negative amounts are expenses/losses; the positive FY2025 share-payment value is a net non-cash benefit, not cash raised.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Current assets exceeded current liabilities at June 2025, with a separate non-current lease liability. The latest full asset detail is less complete than earlier packets, so the report relies on explicit group net assets rather than inventing an asset composition.
A$ million
AI-generated presentation · values from Current resources and net assets; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net assets | 6.337 | 4.873 | 4.785 | 2.539 | 4.559 |
| Current assets | 5.032 | 3.868 | 3.417 | 1.038 | 2.969 |
| Current liabilities | 0.951 | 1.138 | 0.503 | 0.313 | 0.290 |
FY2021-FY2022 net assets calculated from reported consolidated assets less liabilities; later cells are reported totals.
FY2025 current liabilities do not include the separate A$0.135m non-current lease liability.
Positive net assets and working capital do not remove the auditor’s going-concern uncertainty.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The A$3m placement is a component of the approximately A$4.72m annual gross cash raised. Issue costs reduce cash available, and lease repayments also sit within financing cash. The separate share-payment accounting bridge has no place in this cash total.
A$ million
AI-generated presentation · values from Cash equity funding; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Gross share-issue proceeds | 7.427 | 7.000 | 6.100 | 3.000 | 4.723 |
| Cash issue costs | (0.395) | (0.472) | (0.424) | (0.228) | (0.144) |
The FY2025 approximately A$4.72m total includes the A$3m placement component; they must not be added again.
Share-based accounting benefits and scrip paid for assets are not cash financing proceeds.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.